Trial Profile
A Phase 1 bioequivalence study of fosnetupitant and netupitant
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 May 2018
Price :
$35
*
At a glance
- Drugs Fosnetupitant (Primary) ; Netupitant (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 14 May 2018 New trial record